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inTroducTion
Cleft lip and cleft palate are deformities of the face
that are immediately recognized at someone’s birth.
Although they do not consist a fatal health issue in
developed countries, cleft lip and palate (CLP) in-
crease morbidity of affected children and impose a
social stigma on the patients and their families. People
with CLP experience problems with feeding, and com-
munication such as with speaking, hearing and social
integration1. Hearing issues occur more often in chil-
dren with cleft palate. The eustachian tubes cannot
function effectively and the children have conductive
hearing loss, because of middle ear effusion. In that
case, when the air in the middle ear is absorbed, neg-
ative pressure forms  leading to secretion of fluid into
the middle ear. This issues can be addressed either
primarily by surgical correction of the deformity or
by hearing devices later2. Other subsequent issues
that arise can also be corrected to a large degree by
surgery, dental rehabilitation, speech therapy and psy-
chosocial support1.
The etiology of CLP is genetically very heteroge-
neous and this makes it difficult to understand what
biological factors are implicated in its genesis1. More-
over, we need to further investigate how these factors
interact with the environment. We know that several
environmental factors play a crucial role and increase
the prevalence of CLP by interacting with genetic fac-
tors. These include dietary habits, smoking, alcohol
consumption, drug consumption etc1,4,5. As far as the
genetic basis is concerned, there are many syndromes
which contain cleft lip and/or palate as a component
of their phenotype, including Walker-Warburg syn-
drome, van der Woude syndrome, Kallmann syn-
drome, Crouzon syndrome, DiGeorge syndrome,
Muenke syndrome, Pierre Robin Sequence and others.
This is only one side of the story though, since there
are many cases of CLP which cannot be attributed to
a specific syndrome and occur because of single mu-
tations in the human genome. Many genes are impli-
cated, such as IRF6, VAX1, ABCA4, FGFR2,
PDGFC, PVRL1, SUMO1, TGFA, TGFB3, MSX1
speciAl issue
The genetic basis of cleft lip and cleft palate
Christos Veros1, Zafiroula Iakovidou-Kritsi2
1Internal Medicine resident, General Hospital of Nea Ionia Konstantopouleio-Patision, Athens,
2Professor Emerita, Laboratory of Biology and Genetics, Department of Medicine, 
Aristotle University of Thessaloniki, Greece
AbsTrAcT: Cleft lip and cleft palate (CLP) together or as isolated incidents constitute a large proportion of orofacial de-
formities which are observed during birth. It is a medical condition widely researched in the scientific community primarily
because of health effects but also social effects on the everyday life of the affected children. There is wide speculation and
much scientific data about the genes which are implicated on its genesis. CLP can be a clinical feature in many syndromes,
but they can also be observed as isolated incidents in cases  considered as non syndromic. Especially in non syndromic forms
genetic heterogeneity and the differences among studied populations provide us with sometimes conflicting results about
the implicated genes. It is also widely accepted that CLP is a multifactorial medical condition and in its pathogenesis, en-
vironmental factors also play a crucial role.
Key Words: cleft, lip, palate, genetics
Corresponding author: Veros Christos, E-mail: christosveros@yahoo.gr, Tel: 6936181737
and many more27. Recent breakthroughs in genome-
wide linkage and association studies lead to the dis-
covering of new genetic loci which are associated with
CLP. Researchers currently strive to identify and un-
derstand the developmental disturbances that can un-
der circumstances lead to CLP. This knowledge shall
eventually enable us to improve prevention, treatment
and prognosis for individuals with cleft lip and palate
and lead to new approaches regarding clinical care1.
Last but not least, it is of great importance to integrate
genetic counseling in the process of treatment. This
will answer questions of parents as far as the reason
of the appearance of CLP in their family is concerned.
It will also address the concerns about how to raise
their children correctly without medical and/or social
implications, the medical resolution of their situation
and the future possibilities for recurrence in their
family3.
preVAlence
In a population based study of almost 8 million births,
the prevalence of CLP was 9.9 every 10,000 births
worldwide. These data were collected from birth defect
registries from 30 countries between the years 2000
and 20053. This study was consistent with a study con-
ducted in the USA, according to which the prevalence
of CLP was 10.2 per 10,000 births in the United S-
tates.The prevalence of CLP in Western Europe (12.1
per 10,000 births) was similar to the prevalence in the
United States, but the prevalence in Japan (20.0 per
10,000 births) was twice that of the United States.
31% of the cases of CLP in the United States were
CL without CP. Moreover, the same study showed
that 75% of children with CLP during this period were
non-syndromic (no other deformity or only a minor
defect), 8% of cases were associated with a known
syndrome and 17% of cases had several malforma-
tions4. These observations were similar also in Canada,
Western Europe, Japan and Australia3.
seX, AGe And rAce
The prevalence of CLP is different depending on sex,
race, and maternal age. The prevalence of CLP among
males is almost twice as large as that of females. The
prevalence of CLP is lower in non-Hispanic blacks
when compared with non-Hispanic white people.
African Americans have a 44% lower likelihood of
having CLP compared with non-Hispanic whites. Ma-
ternal age younger than 25 years and older than 29
years is associated with an increased risk of CLP com-
pared with mothers aged 25 to 29 years. In ages y-
ounger than 25 or older than 29 no increased risk is
observed compared to the general population3.
enVironmenTAl influences
There are many environmentally-derived factors that
are considered responsible for CLP. Maternal smoking
during pregnancy has been associated with increased
risk of CLP and meta-analysis data strongly support
an odds ratio (OR) of 1.3 for having CLP among chil-
dren of mothers who smoke during gestation1. In a
study conducted in California among women, 70% of
whom were smoking during the 15th to 18th week of
gestation, it was observed that smoking exposures, as
defined by measured cotinine (a nicotine derivative)
levels, were associated with increased risk of CLP.
The study also suggests that the effect may be more
severe in causing bilateral clefts5. It is believed that
genes in certain metabolic pathways may play a role
in the development of CLP, especially during the first
months of intrauterine development of the fetus.
Specifically, GSTT1 (glutathione S-transferase theta)
or NOS3 (nitric oxide synthetase 3) genes appear to
increase the risk of CLP development when combined
with maternal smoking. The GSTT1 markers are gene
deletion variants, a fact which suggests that deficiencies
in intracellular detoxification pathways may increase
susceptibility to CLP. Smoking has also been associ-
ated with a joint risk with markers in the IRF6 gene.
These findings underline the importance of the synergy
between environmental and genetic factors1. Further-
more, there are other mechanisms, such as carbon
monoxide hypoxia, nicotine teratogenic, cadmium or
several amines and alterations to folate metabolism
are considered to be a part of the environmental eti-
ology of CLP5.
Alcohol consumption during pregnancy has also
been suggested as a risk factor. It is suggested that
‘binge’ drinking patterns (i.e. drinking large amounts
of alcohol over a short period of time which leads to
acute intoxication) increase risk, and it is believed
that variations of the ADH1C alcohol dehydrogenase
gene are implicated. These links to alcohol consump-
tion need further confirmation1.
Maternal nutritional habits also seem to play an
important role in the development of CLP in their
children. A link has been demonstrated by many stu -
dies between intake of multivitamins or folic acid dur-
ing pregnancy and a reduced risk for CLP3. Several
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medications widely prescribed have been linked to
CLP when consumed during the first trimester. Folate
antagonists and certain other drugs that exhibit an-
tifolate actions are associated with an increased risk
for CLP. These drugs include anticonvulsants, such
as carbamazepine, valproic acid, phenytoin and phe-
nobarbital among others. Retinoic acid and corticos-
teroids are also considered to be associated with in-
creased CLP risk3. 
Some maternal and obstetric diseases are linked
to CLP in the babies of affected women. Diabetes
mellitus, but not gestational diabetes increases the
risk for several congenital deformities, including CLP.
Maternal obesity (body mass index> 30) is also asso-
ciated with an increased risk for CLP, but the risk is
relatively small, with an odds ratio around 1.32.
Last but not least, CLPs may be caused by me-
chanical conditions, such as amniotic bands that de-
form and disrupt the fetal facial structures2.
syndromes wiTh clefT lip And/or
clefT pAlATe 
walker-warburg syndrome (wws)
Walker–Warburg syndrome (WWS) is a congenital
muscle dystrophy syndrome caused by a-dystroglycan
deficiency. It is associated with brain and eye abnor-
malities. Other abnormalities include cleft lip and
palate (CLP). Mutations in several genes, such as
POMT1, POMT2, fukutin, FKRP and LARGE are
found in 20–30% of children with WWS and are as-
sociated with its deformities6. In a study conducted
on two brothers with WWS and CLP (both were born
from healthy parents), sequence analysis revealed a
new mutation previously not known-. The children’s
phenotype included hypotonia, hydrocephalus,
cataracts, hydronephrosis and CLP. Sequence analysis
of the proband identified mutations in exons 5 and
20 of the POMT1 gene. One mutation, c.291delC,
was not previously reported and is believed to cause
a frameshift resulting in premature stop codon, 124
nucleotides downstream of the deletion. The second
mutation, c.2167insG, which has been reported in
other studies previously, causes a frameshift that is
predicted to remove the 25 aminoacids following G-
ly722. These two mutations in exons 5 and 20 were
inherited from the mother and the father, respectively6. 
Van der woude syndrome (Vws)
This is an autosomal dominant cleft syndrome which
includes bilateral midline lower lip pits, cleft lip, and
cleft palate together with hypodontia. VWS is a rare
congenital syndrome. The lower lip pits which are de-
scribed in patients occur on paramedian portion of
the vermillion border of the lip. Congenital lip pits
occur along with cleft lip and/or cleft palate and rep-
resent the most common clinical manifestation which
is described in 80% of the patients7. There are other
clinical features of VWS which may or may not co-
exist, such as hypoplasia, ankyloglossia, high arched
palate, limb anomalies and congenital heart defects
among others. Most cases of VWS have been associ-
ated with deletion of chromosome 1q32–q41, but an
extra chromosomal locus at 1p34 chromosome has
also been identified8. Many mutations have been i-
dentified in the gene which encodes interferon regu-
latory factor 6 as well. Approximately 30–50% of all
cases though happen because of de novo mutations.
The expression of the syndrome is highly variable; all
of the deformities can be present, either alone or in
combination, or even no abnormalities can be observed
clinically in some cases9.
Kallmann syndrome 
Kallmann syndrome’s estimated prevalence is 1/10,000
in males and at 1/50,000 – 1/70,000 in females10. Spo-
radic cases are more frequent than familial. Kallmann
syndrome is genetically heterogeneous and is expressed
by three modes of inheritance: X-linked due to a mu-
tation in the KAL1 gene (Xp22.3), autosomal domi-
nant due to mutations in fibroblast growth factor re-
ceptor 1 (FGFR1), in KAL2 genes and (8p12) locus
and autosomal recessive which is less usual  and for
which no mutation has been identified till now. KAL1
and KAL2 mutations are included in only 20% of
Kallmann syndrome cases. In Kallmann syndrome
due to KAL1 mutation, a specific phenotype (almost
always hypogonadism and various degrees of anosmia)
is often seen with many associated deformities, such
as unilateral renal agenesis and bimanual synkinesis.
On the contrary, in Kallmann syndrome due to FGFR1
and KAL2 mutations, the phenotype is highly variable
with several degrees of hypogonadism and/or anosmia.
Many malformations have been described in patients
with FGFR1 mutation, such as CLP, teeth agenesis,
bimanual synkinesis, corpus callosum agenesis,  hear-
ing loss, fusion of the fourth and fifth metacarpal
bones (or syndactylia), unilateral nasal cartilage age-
nesis and iris coloboma11.
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crouzon syndrome
Crouzon Syndrome appears with an incidence of 12.5
per million births and is associated with gain-of-func-
tion mutations in FGRF2 gene12. Craniofacial man-
ifestations are its most obvious feature and include
craniosynostosis, hypoplasia of the middle face, oral
anomalies such as an increased incidence of cleft
palate and a constricted dental arch. More than 30 d-
ifferent FGFR2 mutations may lead to Crouzon Syn-
drome, most of which refer to the FGFR2c isoform
and are mesenchymally expressed. All patients with
Crouzon Syndrome are heterozygous for the mutation,
since homozygous mutations are considered to be
lethal13.
In a xenograft study by Alison K. et al cleft palate
occurred in nearly all mice that were homozygous for
the C342Y mutation in the mesenchymal splice form
of FGFR2, which is associated with CS. Mutant em-
bryos presented delayed palate elevation, changes in
palate mesenchymal proliferation, and lower levels
of mesenchymal glycosaminoglycans (GAGs). Lower
levels of feedback regulators of FGF signaling were
also observed and they suggest that this gain-of-func-
tion mutation in FGFR2 is similar to the loss of FGF
function in palate tissue13.
diGeorge syndrome 
DiGeorge syndrome, also called 22q11.2 deletion syn-
drome (22q11DS) is the most commonly observed mi-
crodeletion syndrome14. Its incidence is estimated at
1/2,000–1/4,000 live births. Approximately 9–11% of
patients with this disorder have cleft palate (CP), but
the genetic factors responsible for CP in the 22q11DS
are yet to be found15. The TBX1 gene, a member of
the T-box transcription factor gene family, is located
within the 22q11.2 which is associated with DiGeorge
syndrome. In experiments conducted in mice, inacti-
vation of one allele of Tbx1 does not lead to CP, but i-
nactivation of both alleles does16. Common DNA vari-
ants in TBX1 may also cause CP in patients with
22q11DS. Genes elsewhere on the remaining allele of
22q11.2 or in the genome could be relevant. Although
many candidate genes have been reported from time
to time, it is hard and complicated to establish certain
correlations between genetic mutations and the cleft
phenotype, because of genetic and allelic heterogeneity,
incomplete penetration, and variable phenotypes14.
margarita island syndrome 
Margarita Island syndrome represents a syndromic
form of cleft lip/palate with ectodermal dysplasia. Its
phenotype includes cleft lip/palate, ectodermal dys-
plasia (CLPED), and abnormal fingernails17. Although
that syndrome is rare in general population, CLPED
occurs with a high frequency of nearly 1/2000 among
the inhabitants of Margarita Island, an island located
in the Caribbean Sea of the coast of Venezuela18.
There is a mutation associated with it, which is found
in exon 3 (W185) of poliovirus receptor-like 1 (PVRL)
gene in people from Margarita Island. PVRL1 en-
coding nectin-1 is an immunoglobulin – related trans-
membrane cell-to-cell adhesion molecule which con-
stitutes a part of the cell adhesion system17.
muenke syndrome 
Individuals with Muenke syndrome have the lowest
incidence of cleft palate among craniosynostosis syn-
dromes. Muenke syndrome is also the most common,
with an incidence of 1 in 30,000 births. It is an auto-
somal dominant syndrome caused by a gain-of-function
point mutation in the FGFR3 gene, c.749 C9G, which
results in p.P250R (proline to arginine substitution
at amino acid 250). Patients with Muenke syndrome
clinically have craniosynostosis, carpal and/or tarsal
bone fusion delay in development, and sensorineural
hearing loss. It includes several craniofacial anomalies
such as mild hypoplasia of the middle face, high-arched
palate, and hypertelorism19. Muenke syndrome ac-
counts for 24% of cases of craniosynostosis with a
known genetic cause. Still the frequency of oral and
palatal anomalies including cleft lip with or without
cleft palate has not been documented till now20. Fur-
thermore, cleft lip with cleft palate has not yet been
reported in a patient with Muenke syndrome19.
pfeiffer syndrome
The frequency of cleft palate is known to be high in
some craniosynostosis syndromes which are linked
with fibroblast growth factor receptor 2 (FGFR2),
such as Apert syndrome. However, little do we know
about the frequency of CP in the also FGFR2-linked
deformity called Pfeiffer syndrome. This is an auto-
somal dominant craniosynostosis syndrome, caused
by activating mutations of the FGF receptor 1 (FGFR1)
or FGF receptor 2 (FGFR2) genes21. Apart from CP
which can be present, its clinical features consist of
craniosynostosis, hypoplasia of the middle face, large,
medially deviated thumbs and big toes, syndactyly, ra-
diohumeral synostosis of elbow, and increased airway
obstruction risk due to tracheal stenosis22.
28 Aristotle University Medical Journal, Vol. 43, Issue 2, June 2016
pierre robin sequence (prs) 
The Pierre Robin Sequence (PRS) is a clinical entity
which includes Cleft Palate. Its etiology is generally
unknown but it is widely believed to have a genetic
basis. Clinically PRS is characterized by cleft palate
and micrognathia which leads to glossoptosis, which
means that the tongue tends to obstruct the airway
and therefore causes feeding and respiratory problems
during the early years after birth23. PRS is observed
with a higher frequency in siblings than in general
population (9% versus 1%). This could lead to the
assumption that PRS is a result of the twinning process.
Moreover, the hypothesis that the causative factor is
a mechanical intrauterine constraint also exists. PRS
has the same prevalence in both sexes24.
There are factors that connect PRS syndrome with
a genetic background. Patients with PRS quite often
have also other family members which present cleft
lip or palate in their medical history (13.0%–27.7%)
and PRS is also present in other clinical entities, such
as Stickler syndrome, DiGeorge syndrome, Marshall
syndrome, Treacher Collins syndrome, Catel-Mancke
syndrome, teratogene syndromes and others23. The
most common syndrome which co-exists with PRS is
Stickler syndrome25. In a molecular level, deletions,
duplications translocations and mutations affecting
chromosomes 1 to 6, 10 to 13, and 16 to 18 are in-
volved. Various loci in chromosome 2 (2q24.1-33.3),
chromosome 4 (4q32-qter), chromosome 11 (11q21-
q23.1), and chromosome 17 (17q21- q24.3) are also
involved. There is a large number of possible candidate
genes which are implicated in PRS pathogenesis, such
as GAD67, IDH1, ITGAV, DLX2, PDGFC, PVRL1
and SOX9, too. It has been suggested that GAD67
which is based on chromosome 2q31 is involved in
the etiology of CLP in the Japanese population. Also
there is evidence that the SATB2 gene on 2q32-q33
is responsible for CP. This gene is involved in tran-
scriptional control and is expressed in the palate during
the stages of its development23. Moreover it has been
found that a heterozygote mutation in the PVRL1
gene Margarita Island syndrome). Furthermore, the
transcription factor SOX9 might be an interesting
gene. On chromosome 11q23-q24 is a moderate ge-
netic risk factor for CLP in Venezuela26. Observations
till now show that  mutations in the SOX9 gene and
approximately 1 Mb upstream the SOX9 gene, cause
campomelic dysplasia23. There are many syndromes
which contain CLP as a clinical manifestation, as p-
resented in the following table (Table 1).
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Table 1. Syndromes with CLP as a clinical manifestation1.
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non-syndromic cleft lip and cleft palate (nsclp)
Several genome-wide linkage studies and meta-analyses
have proposed that NSCLP might be connected with
many genetic regions, each one of which has a different
relative risk in different populations. These candidate
loci include IRF6 (1q32.3-q41), VAX1 (10q26.1), AB-
CA4 (1p22.1-21), BMP4 (14q22q23), FGFR2 (10q26),
FOXE1(9q22), MAFB (20q11,2-q13.1), MSX1 (4p16.3-
p16.1), MYH9 (22q13.1), CRISPLD2 (16q24.1),
FGF8 (0q24),GSTT1 (22q11.23), MTHFR (1p36.3),
PDGFC (4q32), PVRL1 (11q23.3), SUMO1 (2q33),
TGFA (2p13), TGFB3(14q24) and others27.
In a study conducted in the Taiwanese population
22 types of gene variants within 10 studied genes in
individuals with non-syndromic CLP were observed.
Single nucleotide variations were found (ABCA4,
MYH9, MTHFR, CRISPLD2, FGF8, PVRL1,
FOXE1 and FGFR2), deletions were estimated
(CRISPLD2 and IRF6 gene) and one duplication was
identified (VAX1). The most frequent risk loci in the
Taiwanese population have been found to be the
MYH9 and the ABCA428.
MYH9, or myosin heavy chain 9, is associated with
non-syndromic CLP in several populations29. High
expression of MYH9 was observed in the palatal
shelves prior to fusion during the developmental pro-
cess. MYH9 is considered to be the most frequent
risk loci in the Taiwanese population, providing sci-
entists with further evidence that MYH9 is involved
in the etiology of nonsyndromic CLP. Also studies
revealed markers in and near the ABCA4 gene, which
indicates a susceptibility locus for CLP, especially in
the Honduran and Colombian populations. 
In the Brazilian population, ABCA4 rs540426 is as-
sociated strongly with CLP, unilateral or bilateral,
while the SNP rs481931 exhibited borderline involve-
ment in the pathogenesis of CLP. However, in a Chi-
nese population, ABCA4 was not found to be asso-
ciated with CLP28. As far as European populations
are concerned Birnbaum et al described the localiza-
tion of a major susceptibility locus for NSCLP on
8q24.21. The region of strongest association is a B
1.7-Mb gene which does not encode any known pro-
tein30. In a study conducted by Scapoli et al in the I-
talian population a strong correlation between loci
of IRF6 gene and NSCLP was established. Individuals
with rs2013162 and rs2235375 markers were found to
have higher prevalence of NSCLP compared with
those who did not have these two markers31. There
are many other genes, which are believed to be asso-
ciated with non-syndromic CLP, as the following table
suggests (Table 2). Subsequently we present some of
the most important genes and loci which are consid-
ered to be etiologic factors of CLP.
10q25
Non-syndromic cleft lip with or without cleft palate
(NSCLP) is a common human defect. A polymor-
phism, rs7078160 in 10q25 loci, has been reported to
be involved in the etiology of the condition but results
are highly variable and conflict with each other. Results
show that rs7078160 on 10q25 loci, the minor allele
A, had a higher risk of NSCLP than the major allele
G. Overall, the results showed that the 10q25rs7078160
polymorphism was involved in the pathogenesis of N-
SCLP. The magnitude of this involvement between
10q25 rs7078160 polymorphism and risk of NSCLP
varied among white, Asian, and mixed populations,
a fact suggesting that ethnic heterogeneity and envi-
ronmental factors can have different influences in
10q25 rs7078160 loci when it comes to NSCLP32.
bcl3 
BCL3 is believed to play a role in the etiology of N-
SCLP as an allele or a modifier locus. BCL 3 (B-cell
leukemia/lymphoma-3) is a proto-oncogene located
at 19q13 that encodes a transcription factor involved
in cell cycle regulation. An association of the BCL3
locus or a nearby locus with NSCLP has been pre-
sented by several studies. More specifically there is
association between the 19q13.2 region which contains
the BCL3 gene and this deformity. Moreover an excess
transmission of the 3 allele (135 bp) at the BCL 3 gene
was observed33.
ofc1 
Different groups have investigated the localization
of CLP gene on chromosome 6 (named OCF1) with
conflicting results though. It is noticed that NSCLP
has been associated with chromosomal aberrations
involving the short arm of chromosome 6 (6p). The
involved loci were included within the 6p24.3 region
near the HGP22 and AP2 genes. The HLA locus, lo-
cated in 6p21.3, has offered both negative and positive
results. A linkage to the 6p24 at F13A locus has also
been found. However, no linkage between NSCLP
and this 6p region was found in other groups34. In an
investigation on 21 nonsyndromic CLP Italian families,
linkage to the 6p23 region was observed35. There is
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Table 2. Genes implicated in non-syndromic CLP 1.
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also evidence in xenograft models that endothelin-1
(EDN1) could be involved in NSCLP36.
irf6
Interferon regulatory factor-6 (IRF6) is a member of
a family of nine transcription factors which regulate
the expression of IFNa and IFNb after viral infection.
Mutation in the IRF6 gene can cause van der Woude
syndrome (VWS) which is associated with CLP. Some
VWS cases, especially those who lack lip pits, are not
easily distinguished from nonsyndromic CLP, raising
the question of whether allelic variety in the VWS lo-
cus could imply nonsyndromic CLP34. A significant
association with the V allele at a val274-to-ile poly-
morphism in the IRF6 gene was found37. 
TGfb3 (locus 14q24)
An etiologic role for TGF- b3 was proposed because
linkage disequilibrium was found in several studies.
Vieira et al. proved an association between cleft palate
alone and TGF- b3, and subsequently a joint analysis
of MSX1 and TGF- b3 together suggested that these
two loci might interact and increase susceptibility to
NSCLP. The distribution of the SfaN1 polymorphism
of TGFb3 is strongly associated with an increased risk
of NSCLP in males, but not in females34. 
rArA (locus 17q21.1) 
There is a significant existing difference between non-
syndromic CLP cases and unrelated controls in the
frequency of alleles at the retinoic acid receptor alpha
(RARa), located at 17q21.1. Genes in the region of
RARa, or its genetic variations are involved in the
formation of CLP. RARa, or a nearby locus, is pri-
marily considered as a modifier of the NSCLP sever-
ity34. On the contrary, other study groups did not find
linkage between RARa and non syndromic clefts.
Peanchitlertkajorn et al. investigated RARa, in Chi-
nese families and found that genetic variety within
the RARa locus is involved in the etiology of non syn-
dromic clefts38.
cleft palate X-linked (TbX22 gene) 
The implicated gene is located in Xq21.3, and the
flanking markers are DXS1196 and DXS1217. It has
been proven that cleft palate chromosome X-linked
is caused by mutations in the gene encoding the T-
box transcription factor TBX22. Members of this fam-
ily play essential roles in early vertebrate development.
An analysis of the TBX22 gene in patients with cleft
palate showed that mutations within families could
result in either cleft palate alone or ankyloglossia
alone, or both34.
ofc5 (msX1 gene) 
It is believed that there is interaction between envi-
ronment factors and MSX1. Indeed, the risk of CLP
related to maternal smoking and alcohol consumption
during pregnancy is increased because of the inter-
action between such exposure and specific allelic vari-
ants of MSX134. A missense mutation in the MSX1
gene in Vietnamese and Filipino CLP patients has
also been found39.
mThfr (locus 1q36)
Methylenetetrahydrofolate reductase (MTHFR) is
located on 1q36 locus and is an important enzyme of
folic acid metabolism. The C677T mutation of MTH-
FR encodes a thermolabile enzyme with reduced ac-
tivity. This characteristic leads to elevated plasma ho-
mocysteine levels and lower plasma folate, because
of reduced MTHFR activity. Fetal homozygosity in
C677T is found to be three times more frequent in
patients with NSCLP than found in controls. Homozy-
gosity for the common folate-related polymorphism
associated with the thermolabile form of MTHFR is
more frequently observed in patients with non syn-
dromic CLP. Homozygosity for either the T or C allele
of C677T polymorphism in females is an important
susceptibility factor for the development the defor-
mity34.
noG polymorphisms 
In a study conducted in the Chinese population it is
suggested that NOG rs227731 polymorphism consti-
tutes decreased risk to NSCLP in a Northern Chinese
population. The NOG rs227731 CC genotype was
found to be uncommon among NSCLP cases40. NOG’s
localization is found on 17q22 and is generally con-
sidered a candidate gene for NSCLP, because inac-
tivation of NOG leads to development of the cleft
palate in xenograft rat models41.In addition, NOG
may cause NSCLP through the BMP signals, which
play an important role in formation of the upper lip
or primary palate. As a result the BMPs are also im-
portant candidate genes for NSCLP42. 
sumo1 
The SNP marker rs7580433 is considered to be asso-
ciated with NSCLP. Given its location within the
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SUMO1 gene, it is not possible that SNP rs7580433
creates a functional change, but it could be possibly
a marker for other unknown SUMO1 polymorphisms.
Also genetic variation that results in SUMO1 hap-
loinsufficiency may contribute to NSCLP. Also animal
model studies support that SUMO1 plays an important
role in CLP development43. 
TGfA 
A significant association has been observed between
transforming-growth-factor-a (TGFA) locus and N-
SCLP. It is believed that either the TGFA gene itself
or DNA sequences in a nearby region contribute to
the development of NSCLP in people. A significant
association between the 2.7 kbp Taq I and the 4.0 kbp
Bam HI fragments of the TGFA probe and nonsyn-
dromic CLP has been observed. This association sug-
gests that an abnormality in this gene may cause a
predisposition for CLP or that a still unidentified
clefting gene may be tightly linked to the TGFA locus.
Furthermore, EGF/TGF-a and glucocorticoids are
believed to play a regulating role in the proliferation
and differentiation of palatal epithelial cells. The con-
tinuous presence of EGF inhibits the fusion process
as well and TGF-a might also have similar effects.
The mutations that affect the timing of the tissue-spe-
cific expression of this gene might be the reason for
the NSCLP deformity. Examinations of the haplotype
distributions also show that there is overrepresentation
of the C2A2B2 and C1A2B1 haplotypes44. 
Genetic counseling
Most parents with a child with either cleft lip or cleft
palate wonder why this happened to their family and
if they are to be blamed for. They may also be worried
about the chances of future reappearance of the de-
formity in other pregnancies. Patients with CLP may
have similar concerns about the health of their own
children. The first step for genetic counseling is taking
medical history and examination. In addition to that
a thorough gestational history is necessary to look for
possible teratogenic factors that have contributed to
the appearance of CLP as well as a detailed family
history to identify genetic factors. In this way, it is
possible to determine if patients have a syndromic or
nonsyndromic CLP, a familial or nonfamilial CLP.
Genetic counseling also contains recommendation to
avoid the appearance of CLP and other deformities
such as the uptake of 400 mg of folic acid every day
during pregnancy. This mainly prevents malformations
regarding the neural tubes but it also protects from
orofacial clefts. Genetic counseling is important for
families of children with CLP. Professionals can help
the parents of an unborn child with CLP understand
their baby’s birth defect and prepare themselves for
a variety of issues that might arise during the child’s
life. Medical advice offered should be discrete non-
judgmental and accurate. This has a huge impact on
the ability of these families to adapt to the needs of
their children and to manage their future expecta-
tions3.
conclusion
Cleft lip and cleft palate along with other orofacial
clefts are a clinical condition which causes facial de-
formities on the affected children and is still a factor
of major morbidity and social stigma both in developed
and developing countries. There are many factors
which contribute to its appearance, both genetic and
environmental. As far as genetic research is concerned,
there is still a lot to be done in order to identify the
mutations which are responsible for CLP development
and possibly create prenatal diagnostic methods. Ge-
netic counseling and surgery also play a crucial role
in understanding and managing the problems that
arise in the everyday lives of the affected children and
their families, improving their quality of life. 
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ΠΕΡΙΛΗΨΗ: Η χειλεοσχιστία και η υπερωιοσχιστία μαζί ή σαν μεμονωμένες περιπτώσεις αποτελούν ένα μεγάλο τμήμα
των σχιστιών του προσώπου, που παρατηρούνται κατά τη γέννηση. Πρόκειται για μια ιατρική κατάσταση, που έχει τύχει
εκτεταμένης έρευνας από την επιστημονική κοινότητα λόγω των επιπτώσεων στην υγεία καθώς και των κοινωνικών
επιπτώσεων στην καθημερινή ζωή των ασθενών. Υπάρχουν πολλές υποθέσεις και πολλά επιστημονικά δεδομένα για τα
γονίδια που εμπλέκονται στη γένεσή τους. Η χειλεοσχιστία και η υπερωιοσχιστία μπορούν να αποτελούν κλινικές εκφράσεις
σε πολλά σύνδρομα, αλλά μπορούν επίσης να εμφανιστούν και σαν μεμονωμένες περιπτώσεις και σε αυτή την περίπτωση
θεωρούνται μη συνδρομικές. Ειδικά στις μη συνδρομικές μορφές η γενετική ετερογένεια και οι διαφορές ανάμεσα στους
μελετώμενους πληθυσμούς μας παρέχουν πολλές φορές αντικρουόμενα αποτελέσματα για τα εμπλεκόμενα γονίδια. Είναι
επίσης ευρέως αποδεκτό ότι η χειλεοσχιστία και η υπερωιοσχιστία είναι μια πολυπαραγοντική ιατρική κατάσταση, στην
παθογένεση της οποίας και οι περιβαλλοντικοί παράγοντες παίζουν σπουδαίο ρόλο.
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